logo
New drug approval system takes Hong Kong closer to biomedical hub goal

New drug approval system takes Hong Kong closer to biomedical hub goal

Hong Kong has good reason to aspire to its own internationally recognised
regime for approving pharmaceutical drugs . Intense global demand for Covid-19 vaccines remains fresh in the memory. The city also happens to rank No 2, behind only New York, as a market for biomedical and pharmaceutical companies to raise capital. To realise this goal, developing independent clinical trial capacity and a regulatory framework comparable with the US Food and Drug Administration would go a long way. It would also raise Hong Kong's standing as a medical innovation hub.
Advertisement
It is therefore good to hear from health authorities that the city will begin reviewing and approving drugs independently in phases from 2026. A new regulatory system is set to begin operating by the end of next year, with more new medications expected to hit the local market before long. To clear the way, the Department of Health has unveiled a plan to set up a centre for the regulation of medical products, with the aim of becoming a recognised international drug regulation authority.
This is the final link in a road map for the development of primary drug evaluation, an approach foreshadowed in Chief Executive John Lee Ka-chiu's 2023 policy address. This will speed up product reviews. Primary evaluation means approving drugs based on their clinical trial data, without relying on registration approval from other regulatory authorities.
A preparatory office for the centre was set up in June last year to study and plan for a drug regulatory regime. The department said primary evaluation was expected to be implemented gradually over five years. To that end, Hong Kong recently opened its first
clinical trial institute , located in a cross-border tech zone.
The development of Hong Kong as a biomedical hub not only means business opportunities for the city, but resonates with vast market potential on the mainland, where people cannot always afford new drugs approved in the US. As a rapidly ageing society, Hong Kong has a multipronged interest in recognition as an Asian pharmaceutical and biomedical hub with big potential for healthcare shaped by biotech and bioscience.
Advertisement
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Are you developing Parkinson's disease? Earwax may show if you are at risk, study says
Are you developing Parkinson's disease? Earwax may show if you are at risk, study says

South China Morning Post

time4 hours ago

  • South China Morning Post

Are you developing Parkinson's disease? Earwax may show if you are at risk, study says

Chinese researchers investigating Parkinson's disease have made a curious discovery related to earwax that could improve the prospects of prevention and diagnosis. A team based at Zhejiang University in Guangzhou has found that earwax tests could help with the early detection of the debilitating disease, which is difficult to treat and has no cure. Earwax from people with Parkinson's disease were significantly different than the earwax from people without the disease,' according to the American Chemical Society, which published the team's findings. The researchers were following up on previous work showing that Parkinson's sufferers' sebum – an oily substance secreted through the skin – has a different odour than that of people without the disease. Since earwax is largely made up of sebum, the team realised it would make for a potentially telling research target. Earwax is a naturally occurring substance produced in the ear canal to protect and clean the ear. Photo: dpa After screening samples taken from more than 200 people, the team found alterations in four volatile organic compounds – organic chemicals that easily evaporate into the air – in Parkinson's patients' earwax. These changes do not appear in the compounds in the sebum of those who do not have Parkinson's.

Thailand's doctors have to show cannabis use for medical reasons in new form
Thailand's doctors have to show cannabis use for medical reasons in new form

South China Morning Post

time6 hours ago

  • South China Morning Post

Thailand's doctors have to show cannabis use for medical reasons in new form

Thailand has introduced a new prescription form as part of its measures to restrict cannabis usage for medical purposes, just three years after it became the first country in Asia to decriminalise the drug. Advertisement Issued on Monday, the 'P.T.33' form will allow practitioners from seven professions — including doctors, dentists, pharmacists and traditional healers — to prescribe cannabis to patients suffering from 15 health conditions, according to a report from the Thaiger news website. Doctors will be required to record in each prescription form patient details, including name, age, nationality, identification number, diagnosed symptoms, daily cannabis dosage, duration of use and total quantity to be dispensed. The amount sold will be limited to 30 days' supply for each prescription, and dispensers are required to keep such records for one year for government inspections. The prescription form, which will apply to both locals and foreigners, will take effect soon. A cannabis farm in Kanchanaburi province, Thailand. Photo: AP It follows an order signed by Thai Public Health Minister Somsak Thepsuthin last week, reclassifying cannabis as a controlled herb and banning dispensaries from selling it to those without medical prescriptions.

‘Unpolluted, untouched': why In Lieu is sourcing ‘premium water' from Henan, explains start-up founder and CEO Joanne Zhou, offering Hong Kong consumers a more sustainable, healthy choice
‘Unpolluted, untouched': why In Lieu is sourcing ‘premium water' from Henan, explains start-up founder and CEO Joanne Zhou, offering Hong Kong consumers a more sustainable, healthy choice

South China Morning Post

time11 hours ago

  • South China Morning Post

‘Unpolluted, untouched': why In Lieu is sourcing ‘premium water' from Henan, explains start-up founder and CEO Joanne Zhou, offering Hong Kong consumers a more sustainable, healthy choice

'Tap water, purified water, distilled water – these are the most prevalent and common choices in Hong Kong,' says Joanne Zhou. Founder and CEO of start-up In Lieu, Zhou wants to supplement our shop-bought options with what she says is the city's first premium sustainable water brand. Having launched In Lieu in February, Zhou cites studies about the rising rates of chronic illnesses in young people as the main reason why we should start paying more attention to this humble yet vital elixir of life. 'People are shifting their behaviour,' says Zhou. 'Gen Z, millennials are embracing sobriety. The health and wellness trend is booming. And people started to realise they're getting sick easily, dealing with a lot of stress and looking for solutions.' 'They don't trust the current beverage industry,' she concludes. 'When your options are so narrow, people start to pay attention. What kind of water should I drink ? What kind of minerals, electrolytes will I get?' Advertisement In Lieu is a Hong Kong-based start-up offering an upmarket alternative to mineral water sold in plastic bottles. Photo: Handout In Lieu, which has a growing footprint with partnerships and placements at Art Central, as well as with the Midnight Runners community in Hong Kong, was born largely in response to these concerns. After working in the US – where water options are more plentiful, and even celebrities like Beyoncé and Jaden Smith have joined the business – Zhou came back to Hong Kong to find that much of the drinking water on our store shelves is distilled and therefore devoid of the naturally occurring minerals that make it good for you. Still other shop-bought water is 'mineralised' – distilled or otherwise purified, with certain minerals added. 'Some bottled waters don't differ too much from tap water,' Zhou says. 'For the two major brands we know from Hong Kong, they just source their water from the tap system everyone gets from home, which is Dongjiang East River water from China – then use their facility to process and bottle it.' A homonym of l'eau (French for 'water'), the Chinese word liu (meaning 'stream' or 'flow'; it's actually pronounced 'lyoh') provided inspiration for the brand's name. And since the phrase 'in lieu' means 'instead of', the brand's name serves as a succinct mission statement. As opposed to artificially processed options, Zhou hopes that today's more discerning, health-conscious consumers will opt for In Lieu's 'unpolluted, untouched' water sourced from an underground aquifer in China's Dabie Mountains, in Henan province. 'From source to bottling, no human touch, no nothing,' she says. Besides natural mineral water, In Lieu also sells a hydrogen-enriched product. Photo: Handout For something so universally available, it is surprising how variable even tap water is, with different natural sources meaning the minerals it contains can vary widely from place to place. Zhou says not all water is created equal. 'It's so easy for [European consumers] to get quality water,' she says. 'They can just [turn on] the tap. If you live in the Alps, the cleanest water comes out, versus here, [where] most of the water needs to be processed and people don't have the privilege to appreciate high-quality water.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store